Archive:
In February 2022, the G-BA's Innovation Committee gave the green light: It is recommended that the health kiosk in Hamburg's Billstedt and Horn districts be included in regular care. Since then, attention has been growing around the low-threshold case management model – politically and in the media. At the end of August, Federal Health Minister Prof. Karl Lauterbach presented key points for the nationwide development of health kiosks. But who can actually set up a health kiosk? Who should particularly benefit from this? How should employees be qualified? And is the concept also suitable for rural areas? Dr. Oliver Gröne, deputy chairman of the board, and Anja Klose, Project & Healthcare Manager at OptiMedis, gave initial answers in the company's own newsletter.
21.09.2022
“From project funding to innovation infrastructure” is what the Federal Association of Managed Care e. V. its current position paper on the further development of the Innovation Fund (IF). Six years after its launch, it is time to fundamentally further develop the innovation fund in order to make better use of the associated opportunities than before. Instead of the current project funding, the BMC advocates an innovation infrastructure that sustainably develops the health system. To do this, politicians must clearly state which goals the fund should achieve - in particular, the focus must be on actually improving standard care - and create practical conditions for testing innovations.
21.09.2022
The collective agreement regulations for statutory health insurance were supplemented in 2019 to include second opinion procedures. If an insured person is planning to have an operation on the palatine or pharyngeal tonsils (tonsillectomy, tonsillotomy), a hysterectomy, a joint endoscopy of the shoulder (shoulder arthroscopy), an implantation of a knee endoprosthesis, an amputation for diabetic foot syndrome or an operation on the spine , then in addition to the doctor who gave the indication (first opinion), you can also ask a second doctor for medical advice (§ 27b SGB V; Federal Joint Committee 2022). In issue 03/2022 of the “Monitor Healthcare Research” it was already possible to analyze billing data and catchment areas for selected indications in the Hesse health insurance area. The presumed influences and incentives on service provision and utilization were identified (Hartweg/Suk 2022). But in addition to these collective agreement offers, many health insurance companies have now also established their own second opinion procedures. These second opinion procedures are the focus of this article.
21.09.2022
The abolition of the supplementary federal subsidy in 2023, which will provide an additional 14 billion euros in the coffers of statutory health insurance (GKV) in 2022 (Bundestag 2021), thus increasing the total amount to 28.5 billion euros, gave rise to a debate about the impending funding gap for statutory health insurance in 2023. The question therefore arises as to which measures are suitable to enable targeted expenditure control in the statutory health insurance. The federal government's draft law for the financial stabilization of statutory health insurance (Federal Ministry of Health 2022) lists a number of measures that are intended to realize efficiency reserves without benefit cuts amounting to around 3 billion euros for 2023. For example, the sales threshold for drugs to treat a rare disease (orphan drugs) for the benefit assessment is to be reduced to 20 million euros.
21.09.2022
There are now some results reports and transfer resolutions that reveal a fundamental problem with the existing transfer regime: methodological problems and the sometimes very specific project design limit the generalizability of the results (BT-Drs. 20/1361, p. 152 ff.). As a result, it is often not possible to make sound transfer recommendations. Since more projects are continually ending and the current federal government also plans in its coalition agreement to perpetuate the innovation fund and specify a more binding path for the project transfer into standard provision (SPD; Alliance90/The Greens; FDP 2021, p. 86 f.), one Development of relevant solutions is essential. After first looking at the problem in more detail below, this article proposes a solution based on common scientific procedures: bringing together findings from related projects through systematic reviews as an extraordinary and permanent thematic focus. Furthermore, this would also take up the suggestion identified in the Prognos report to “[…] synthesize and jointly evaluate the results within selected subject areas in order to create further evidence for certain innovative forms of care (e.g. pilotage projects) on this basis to disseminate implementation-relevant knowledge” (BT-Drs. 20/1361, p. 208).
21.09.2022
According to estimates, around 260,000 people in Germany are affected by a stroke every year [1]. Numerous underlying diseases can result in the spastic syndrome (SMD; synonymous use: spastic movement disorder, spasticity, spasticity). The manifestation of the spastic syndrome is possible at different times in the course of the respective underlying disease [2,3]. In addition to multiple sclerosis, a craniocerebral trauma, a spinal cord lesion or cerebral palsy, stroke is one of the most common and causative underlying diseases [4]. Stroke survivors have almost a 50% chance of developing spasticity one to three months later [5,6]. Spastic movement disorders are damage to the central nervous system and the central nervous sensorimotor cell and pathway systems (“spastic movement disorder”, SMD). The disease is characterized by a massive limitation of joint mobility and therefore overall mobility, as well as involuntary activation of muscles [7]. In Germany, 250,000 people are probably affected and suffer from the disease and the associated reductions in quality of life [8].
21.09.2022
8. Ad hoc statement on the pandemic caused by SARS-CoV-2/Covid-19 - see OnlineFirst
19.09.2022
Von den weltweit circa 11 Millionen sepsis-assoziierten Todesfällen hält die WHO die Mehrzahl für vermeidbar. Hierfür gibt es zwei wesentliche Ansatzpunkte: erstens die Prävention von Infektionen und zweitens die frühzeitige Erkennung von Sepsis-Symptomen, denn eine Sepsis ist ein medizinischer Notfall, bei dem jede zeitliche Verzögerung die Prognose verschlechtert. Da seit langem bekannt ist, dass in Deutschland das Sepsis-Wissen älterer Menschen, die per se einer Risikogruppe angehören, gering ist (Eitze et al. 2018), fördert das Bundesgesundheitsministerium seit Juli 2021 den Aufbau der Kampagne „Deutschland erkennt Sepsis“ (1), die vom Aktionsbündnis Patientensicherheit, dem Sepsis-Dialog der Universitätsmedizin Greifswald, der Deutschen Sepsis-Hilfe sowie der Deutschen Sepsis-Stiftung gemeinsam umgesetzt wird.
02.08.2022
Der 21. Deutsche Kongress für Versorgungsforschung, der vom 5. bis 7. Oktober 2022 in Potsdam stattfinden wird, steht unter dem Motto „Versorgungsforschung – Nutzen für die klinische Praxis – Potentiale und Perspektiven“. Es solle, so schreibt Prof. Dr. med. Peter Falkai in seiner Begrüßung als Kongresspräsident, zuvörderst diskutiert werden, „welchen Nutzen die Versorgungsforschung für die klinische Realität und somit konkret für Patient:innen bereithält“. Was Falkai, hauptberuflich Direktor der Psychiatrischen Klinik des LMU Klinikums München, darunter versteht, erklärt er im Titelinterview von „Monitor Versorgungsforschung“. Seine wichtigsten Hauptforderungen: Vernetzung, Replizierbarkeit, Qualitätsstandards und -kontrolle sowie „Back Translation“.
31.07.2022
With the MVF specialist conference “Theory Dare” in December 2021 and the MVF theory kit, “Monitor Healthcare Research” would like to focus the attention of healthcare researchers on the topic. Even if there is a “fundamental conflict between basic and applied research,” as Prof. Dr. Holger Pfaff (Director of the Institute for Medical Sociology, Health Services Research and Rehabilitation Science in Cologne) states that Prof. Dr. Jörg Sydow (Chair of Corporate Cooperation in the Management Department of the Free University of Berlin) countered in a keynote interview with “Monitor Healthcare Research” that it was always worthwhile to deal with theories because they acted “like an intelligent magnifying glass”: “You know exactly what you see more clearly.”